Sanofi’s Dengvaxia immunisation could worsen disease in some patients not previously exposed to virusThe Philippines has ordered an investigation into the immunisation of more than 730000 children with a dengue vaccine that has been suspended following an announcement by French drug company Sanofi that it could worsen the disease in some cases. The World Health Organisation said it hoped by the conclude of the year to conduct a full review of data on the vaccine,commercially known as Dengvaxia. In the meantime, the WHO recommended it be used only in people who had a prior infection with dengue. Continue reading...
Source: guardian.co.uk